XNCR - Xencor Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - XNCR (1326732)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
38 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S7-1-4-7+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2018-09-17
XNCRFoster Paul AChief Medical OfficerS - Sale+OE$46.03-40,0004,952-89%-$1,841,208
2018-09-14
XNCRStafford John S III10%S - Sale$48.05-1,0005,017,8480%-$48,054
D
2018-08-17
XNCRFoster Paul AChief Medical OfficerS - Sale+OE$40.10-3,6594,952-42%-$146,726
DM
2018-08-14
XNCRFoster Paul AChief Medical OfficerS - Sale+OE$41.10-36,3414,952-88%-$1,493,710
DM
2018-08-09
XNCRBaracchini Edgardo JrChief Business OfficerS - Sale+OE$40.16-50,000207-100%-$2,008,117
DM
2018-08-09
XNCRDesjarlais John RSVP, Research, CSOS - Sale+OE$40.36-35,00088,098-28%-$1,412,721
M
2018-07-13
XNCRStafford John S III10%S - Sale$41.42-111,7005,018,848-2%-$4,626,479
M
2018-07-10
XNCRStafford John S III10%S - Sale$39.69-138,3005,130,548-3%-$5,489,265
M
2018-06-18
XNCRStafford John S III10%S - Sale$39.90-250,0005,261,348-5%-$9,974,392
D
2018-06-15
XNCRDahiyat Bassil IPres, CEOS - Sale+OE$40.51-50,000343,067-13%-$2,025,690
D
2018-06-13
XNCRKuch John JSVP, CFOS - Sale+OE$41.64-25,00092,482-21%-$1,040,945
D
2018-03-15
XNCRBaracchini Edgardo JrChief Business OfficerS - Sale+OE$30.89-40,0000-100%-$1,235,744
DM
2018-03-02
XNCRBaracchini Edgardo JrChief Business OfficerS - Sale+OE$29.59-20,0000-100%-$591,806
D
2018-02-27
XNCRBaracchini Edgardo JrChief Business OfficerS - Sale+OE$29.64-20,0000-100%-$592,848
D
2018-02-22
XNCRBaracchini Edgardo JrChief Business OfficerS - Sale+OE$26.00-8,0690-100%-$209,794
D
2018-02-22
XNCRFoster Paul AChief Medical OfficerS - Sale+OE$26.03-10,0002,419-81%-$260,300
D
2018-02-16
XNCRFoster Paul AChief Medical OfficerS - Sale+OE$25.01-5,0002,419-67%-$125,050
M
2017-12-12
XNCRStafford John S III10%P - Purchase$20.76+9,2155,511,3480%+$191,280
M
2017-11-24
XNCRStafford John S III10%P - Purchase$19.86+15,3745,502,1330%+$305,274
M
2017-11-08
XNCRStafford John S III10%P - Purchase$19.91+41,8235,485,183+1%+$832,608
M
2017-11-03
XNCRStafford John S III10%P - Purchase$19.85+27,8095,443,360+1%+$551,942
M
2017-10-31
XNCRStafford John S III10%P - Purchase$19.58+50,0005,415,551+1%+$979,036
M
2017-10-25
XNCRStafford John S III10%P - Purchase$19.81+150,00010,681,102+1%+$2,970,892
M
2017-08-21
XNCRStafford John S III10%P - Purchase$19.69+41,0165,215,551+1%+$807,591
M
2017-08-16
XNCRStafford John S III10%P - Purchase$20.39+147,5355,174,535+3%+$3,008,406
M
2017-08-10
XNCRStafford John S III10%P - Purchase$21.13+27,0005,027,000+1%+$570,490
2017-06-28
XNCRStafford John S III10%P - Purchase$19.94+6,0005,000,0000%+$119,640
2017-06-16
XNCRStafford John S III10%P - Purchase$19.67+1,5004,994,0000%+$29,510
2017-06-14
XNCRCarter Bruce L ADirS - Sale$20.61-20,00048,578-29%-$412,238
2017-06-02
XNCRCarter Bruce L ADirS - Sale$22.00-2,36668,578-3%-$52,052
D
2017-05-26
XNCRCarter Bruce L ADirS - Sale+OE$22.19-12,40070,944-15%-$275,213
DM
2017-05-01
XNCRBaracchini Edgardo JrChief Business OfficerS - Sale+OE$26.01-10,5680-100%-$274,917-1-2
D
2017-04-27
XNCRBaracchini Edgardo JrChief Business OfficerS - Sale+OE$26.04-9040-100%-$23,5400-6
D
2017-03-16
XNCRKuch John JVP, FinanceS - Sale+OE$24.42-15,00077,171-16%-$366,278+1-2-7
2017-03-15
XNCRDesjarlais John RSVP, Research, CSOS - Sale$24.47-13,75587,676-14%-$336,637+1-2-7
D
2017-03-08
XNCRBaracchini Edgardo JrChief Business OfficerS - Sale+OE$25.00-1,8210-100%-$45,525-2-3-7
D
2016-12-05
XNCRDesjarlais John RSVP, Research, CSOS - Sale+OE$26.57-45,000101,381-31%-$1,195,515+1-5-4
2016-12-06
XNCRStafford John S III10%S - Sale$27.70-63,0614,992,500-1%-$1,747,105-5-10-9
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top